Neurotraining for Concussion
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new approach to improve brain functions such as working memory and attention in individuals with mild traumatic brain injury (mTBI), commonly known as a concussion. Participants will engage in PATH neurotraining, which consists of computer-based exercises designed to enhance memory and processing speed. Researchers will test three different training schedules to determine the most effective routine. Individuals who have experienced one or more concussions and have ongoing memory issues might be suitable candidates for this trial. As an unphased trial, it offers participants the chance to contribute to innovative research that could lead to new treatment options for mTBI.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you have a diagnosis of epilepsy, seizure disorder, major depressive disorder, or severe anxiety, you may not be eligible to participate.
What prior data suggests that this neurotraining is safe for mTBI patients?
Research shows that PATH neurotraining is generally well-tolerated. Studies have found that participants in PATH neurotraining have experienced improvements in cognitive skills, such as memory and focus, without major side effects. The treatment involves exercises to retrain brain pathways, akin to a mental workout routine.
Although studies do not specifically mention negative effects, the absence of such reports suggests the treatment is relatively safe. As this is an early-phase trial, the researchers are still collecting safety data, but initial results indicate that participants have not encountered major problems.12345Why are researchers excited about this trial?
Researchers are excited about PATH neurotraining for concussions because it offers a non-invasive, cognitive approach to recovery, unlike the typical rest and gradual return to activities. This technique uses adaptive computer-based exercises that adjust in difficulty to enhance visual and memory skills, potentially speeding up cognitive recovery. By combining tasks that challenge both visual contrast and memory recall, PATH neurotraining aims to improve brain function more effectively than current methods. Additionally, the flexibility in training frequency—ranging from once to three times a week—allows personalization to fit individual needs and schedules.
What evidence suggests that this trial's treatments could be effective for mTBI?
Research has shown that PATH neurotraining, one of the treatments studied in this trial, can improve mental skills like memory and focus, often affected after a concussion. One study found that participants using PATH improved their visual memory by 35%, outperforming other methods tested. PATH retrains the brain to process visual information more accurately and quickly. This enhancement in visual timing can boost other related mental skills. Overall, PATH neurotraining appears promising for helping individuals with mild brain injuries regain important mental abilities. Participants in this trial will receive PATH neurotraining combined with digit memory exercises at varying frequencies to assess its effectiveness.23467
Who Is on the Research Team?
Teri Lawton, Ph.D.
Principal Investigator
Perception Dynamics Institute
Are You a Good Fit for This Trial?
This trial is for individuals aged 18-60 who have had a mild traumatic brain injury (mTBI) and score between 19-25 on the MoCA test. Participants must read English, have corrected 20/20 vision, and be able to commit time to complete the study. Those with post-traumatic amnesia over 24 hours, recent mTBI (<3 months), or certain cognitive impairments are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo PATH, N-Back WM, or Sham neurotraining for cognitive improvement
Follow-up
Participants are monitored for safety and effectiveness after treatment
Open-label extension (optional)
Participants may opt into continuation of treatment long-term
What Are the Treatments Tested in This Trial?
Interventions
- N-Back Working Memory Training
- Orientation Discrimination
- PATH neurotraining
Find a Clinic Near You
Who Is Running the Clinical Trial?
Perception Dynamics Institute
Lead Sponsor
University of South Alabama
Collaborator
University of California, San Diego
Collaborator
University of California, Riverside
Collaborator